1. Cendrowski, W., 1966, Concerning the reaction to encephalitogenic factor in familial multiple sclerosis, Archivum Iimunologiae et Therapiae Experimentalis l4:491.
2. Cendrowski, W., and Murawski, K., 1966, Skin reactions to myelin antigen and purified encephalitogenic factor in multiple sclerosis, Archivum Immunologiae et Therapiae Experimentalis 14:164.
3. Field, E.J., 1965, Some observations on the clinical immunology of multiple sclerosis. In Slow, Latent and Temporate Virus Infections, Monograph 2, pp. 187–192, National Institute of Neurological Diseases and Blindness, Washington, D.C.
4. Davis, L.E., Hersh, E.M., Curtis, J.E., Lynch, R.E., Ziegler, D.K., Neumann, J.W., and Chin, D.Y., 1972, Immune status of patients with multiple sclerosis: analysis of primary and established immune responses in 24 patients. Neurology 22:989.
5. Sever, J.L., and Kurtzke, J.F., 1969, Delayed dermal hypersensitivity to measles and mumps antigens among multiple sclerosis and control patients. Neurology 19:113.